Novavax Nuvaxovid COVID-19 Vaccine authorized in the United Kingdom for use as a booster in adults
On Nov. 9, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
Novavax phase 3 COVID-19 Omicron trial supported continued and future use of prototype vaccine as a booster
On Nov. 8, 2022, Novavax announced topline results from its Phase 3 Boosting Trial for the SARS-CoV-2 rS…
First ever clinical trial of laboratory grown red blood cells being transfused into another person
On Nov. 7, 2022, the NHS Blood and Transplant (NHSBT) reported that red blood cells grown in a…
USDA confirmed highly pathogenic Avian influenza in commercial chickens in Mississippi
On Nov. 5, 2022, the U.S. Department of Agriculture’s (USDA) Animal Plant Health Inspection Service (APHIS) confirmed the…
Oregon Department of Agriculture confirmed highly pathogenic Avian influenza in Yamhill County
On Nov. 4, 2022, the Oregon Department of Agriculture (ODA) and the U.S. Department of Agriculture’s (USDA) Animal…
Moderna received Health Canada authorization for second Omicron-targeting bivalent booster
On Nov. 4, 2022, Moderna announced that Health Canada had authorized the use of its BA.4/BA.5 Omicron-targeting bivalent…
USDA confirmed highly pathogenic Avian influenza in two non-commercial backyard flocks in Arizona and South Carolina
On Nov. 4, 2022, the U.S. Department of Agriculture’s (USDA) Animal Plant Health Inspection Service (APHIS) confirmed the…
Pfizer and BioNTech announced updated data for Omicron BA.4/BA.5-adapted bivalent booster
On Nov. 4, 2022, Pfizer and BioNTech announced updated data from a Phase 2/3 clinical trial demonstrating a…
$1.5 million gift supports Canine Genetics Lab at University of Missouri
On Nov. 3, 2022, the University of Missouri announced a $1.5 million gift from the Orthopedic Foundation for…
Hologic announced contract with BARDA to support IVD approval of COVID assays
On Nov. 2, 2022, Hologic announced that it had been awarded a $19 million contract from the Biomedical…
AIM ImmunoTech received Orphan Drug Designation for Ampligen (rintatolimod) for treatment of Ebola virus disease
On Nov. 2, 2022, AIM ImmunoTech announced that the U.S. Food and Drug Administration had granted Orphan Drug…
USDA announced $30 million American Rescue Plan funding opportunity supporting research on SARS-CoV-2 in animals
On Nov. 1, 2022, the U.S. Department of Agriculture announced it was making $30 million in American Rescue…
Biotechnology | COVID-19 | Diagnostics | Disease | NIH | Therapeutics
NIH-funded study showed blood pressure levels rose during pandemic
On Nov. 1, 2022, the National Institutes of Health (NIH) announced that adults with hypertension saw a small,…
Pfizer announced positive top-line data of phase 3 global trial for bivalent RSV vaccine candidate
On Nov. 1, 2022, Pfizer announced positive top-line data from the Phase 3 clinical trial (NCT04424316) MATISSE (MATernal…
JAMA reported alcohol related deaths due to excessive alcohol use among US adults 2015 to 2019
On Nov. 1, 2022, study results published in JAMA found that estimates in this cross-sectional study of 694,660…
Zimbabwe became first in Africa to announce regulatory approval for long-acting injectable cabotegravir for HIV prevention
On Nov. 1, 2022, the Medicines Control Authority of Zimbabwe announced that it had approved the use of…
Monoclonal antibody prevented Malaria infection in African adults
On Oct. 31, 2022, the National Institutes of Health announced that a clinical trial had found that one…
Japan approved partial change to a NDA for Omicron-targeting bivalent booster COVID-19 vaccine
On Oct. 31, 2022, Moderna announced that it had received approval from the Ministry of Health, Labour and…
Abbott’s FreeStyle Libreﾮ was named Best Medical Technology in Last 50 Years by the Galien Foundation
On Sept. 3, 2014, the Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences,…
INOVIO Discontinued internal efforts to develop INO-4800 as COVID-19 heterologous booster vaccine Candidate
On Oct. 27, 2022, Inovio Pharma announced that it has discontinued its internally funded efforts to develop INO-4800…
USDA dashboard shows broad view of Avian influenza in wild birds by U.S. County
On Oct. 27, 2022, the U.S. Department of Agriculture’s Animal Plant Health Inspection Service (APHIS) confirmed the presence…
Biotechnology | Diagnostics | Disease | NIH | Oncology | Therapeutics
Reported cancer deaths continued downward trend; modest improvements in survival for pancreatic cancer
On Oct. 27, 2022, the National Institutes of Health (NIH) announced that overall cancer death rates continued to…
Tuberculosis deaths and disease increased during the COVID-19 pandemic
On Oct. 27, 2022, the World Health Organization reported that an estimated 10.6 million people fell ill with…
Karmanos completed $48 million expansion at Farmington Hills cancer center
On Oct. 26, 2022, the Barbara Ann Karmanos Cancer Institute announced it had completed an over 50,000-square-foot expansion…
NIH awarded USC $11.7 million to develop implantable devices for the nervous system
On Oct. 26, 2022, the NIH announced it had awarded the University of Southern California (USC) $11.7 million…
University of Washington reported global COVID cases will increase in coming months, but at a slower pace
On Oct. 25, 2022, the University of Washington reported that daily global COVID-19 infections were projected to rise…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Nanotechnology | Therapeutics | Vaccine
COVID-causing virus in air detected with high-tech bubbles
On Oct. 25, 2022, Pacific Northwest National Laboratory (PNNL) announced that scientists have shown that they can detect…
NIH awarded University of Missouri $8 million grant to expand National Swine Resource and Research Center
On Oct. 25, 2022, the National Institutes of Health (NIH) announced that the University of Missouri had been…
EC expanded Merckﾒs VAXNEUVANCEﾙ indication to include infants, children and adolescents
On Oct. 24, 2022, Merck announced that the European Commission had approved an expanded indication for VAXNEUVANCEﾙ (Pneumococcal…
Biotechnology | HIV | NIH
Early HIV diagnosis and treatment important for better long-term health outcomes
On Oct. 24, 2022, the National Institutes of Health announced that starting antiretroviral treatment (ART) early in the…